Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
02:02pm, Wednesday, 12'th Oct 2022 Benzinga
Upgrades
For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte
Where Masimo Stands With Analysts
01:24pm, Wednesday, 12'th Oct 2022 Benzinga
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
1
2
0
0
Last 30D
1
0
0
Masimo, ChannelAdvisor See Activist Action
06:52pm, Friday, 30'th Sep 2022
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
Accenture Price Target Cut By This Analyst, Plus Deutsche Bank Predicts $483 For FactSet Research
12:14pm, Friday, 23'rd Sep 2022 Benzinga
Credit Suisse cut FedEx Corporation (NYSE: FDX) price target from $246 to $236. FedEx shares fell 1.9% to $151.56 in pre-market trading.
Deutsche Bank cut FactSet Research Systems Inc. (NYSE: FDS)
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
02:16pm, Thursday, 15'th Sep 2022 Benzinga
Upgrades
For Nokia Oyj (NYSE:NOK), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the second quarter, Nokia had an EPS of $0.11, compared to year-ago quarter EPS of $0.11. At
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
02:07pm, Wednesday, 14'th Sep 2022 Benzinga
Upgrades
For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low
Where Masimo Stands With Analysts
01:31pm, Wednesday, 14'th Sep 2022 Benzinga
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
0
1
0
0
Last 30D
1
0
Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2022 Update
04:42am, Tuesday, 06'th Sep 2022 Seeking Alpha
Fundsmith filed their regulatory 13F Form on 8/15/2022. What were the latest stake disposals, increases and decreases? Click here to find out.
Masimo's (MASI) Latest Watch to Improve Patient Outcomes
01:28pm, Monday, 05'th Sep 2022 Zacks Investment Research
Masimo's (MASI) full-market consumer release of the Masimo W1 and other related launches is likely to significantly improve RPM.
Masimo's (MASI) Latest Watch to Improve Patient Outcomes
10:32am, Monday, 05'th Sep 2022
Masimo's (MASI) full-market consumer release of the Masimo W1 and other related launches is likely to significantly improve RPM.
How activist Politan Capital may find an opportunity to trim costs, build value at Masimo
08:42am, Saturday, 20'th Aug 2022
Politan Capital has an 8.4% stake in pulse oximetry company Masimo. There may be an opportunity to help the company trim costs.
New York Times, Masimo See Activist Action
05:53pm, Friday, 19'th Aug 2022
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
Inflation and Market News
01:45pm, Wednesday, 17'th Aug 2022 The Motley Fool
Plus we talk with Marsha Barnes, founder and CEO of The Finance Bar, about the mindset traps that can keep people from investing.
Activist Politan Capital Has 9% Stake in Masimo
06:00pm, Monday, 15'th Aug 2022
The medical-device company's shares plummeted earlier this year when it entered into an ill-received acquisition deal.
Masimo's (MASI) Q2 Earnings Surpass Estimates, Margins Down
01:37pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Masimo's (MASI) robust product shipments and strength in its healthcare business drive its Q2 sales.
